Status:
COMPLETED
Aspirin-Myocardial Infarction Study (AMIS)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
30-69 years
Phase:
PHASE3
Brief Summary
To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.
Detailed Description
BACKGROUND: It had been postulated that thrombosis plays a major role in the late stages of coronary artery occlusion. Platelet aggregation is a large component in the formation of arterial thrombi. ...
Eligibility Criteria
Men and women, ages 30 to 69. Had a documented myocardial infarction.
Key Trial Info
Start Date :
October 1 1974
Trial Type :
INTERVENTIONAL
End Date :
August 1 1979
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000491
Start Date
October 1 1974
End Date
August 1 1979
Last Update
March 25 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.